Finland· FI-REL-REL59673
TECVAYLI
A teclistamab product containing teclistamab, registered in Finland by Janssen-Cilag International NV. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Teclistamab is registered in 14 of 19 countries.
Countries holding a registration under ATC L01FX24 (teclistamab), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Teclistamab · ATC L01FX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Teclistamab
- Manufacturer
- Janssen-Cilag International NV
- Country
- Finland (FI)
- ATC code
- L01FX24
- ATC class
- Teclistamab
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa436579153 mgEUR 4777.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teclistamab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaTECVAYLIJANSSEN INC
- SwitzerlandTecvayli 153 mg/1.7 ml, InjektionslösungJanssen-Cilag AG
- CzechiaTECVAYLIJanssen-Cilag International N.V., Beerse
- SpainTECVAYLI 10 MG/ML SOLUCION INYECTABLEJanssen-Cilag International N.V
- FranceTECVAYLI 10 mg/mL, solution injectableJANSSEN CILAG INTERNATIONAL NV
- United KingdomTecvayli 153mg/1.7ml solution for injection vialsJanssen-Cilag Ltd
- IrelandTECVAYLI 10 mg/mL solution for injectionJanssen-Cilag International NV
- IcelandTecvayliJanssen-Cilag International NV*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tecvayli
- Liechtenstein · Tecvayli
- Norway · Tecvayli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2426f46-e0d9-4083-828e-62c8810f2ec5 GET /v1/drugs/b2426f46-e0d9-4083-828e-62c8810f2ec5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Ihon alle",
"ddd_unit": null,
"strength": "90 mg/ml",
"atc_label": "teklistamabi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/22/1675/002",
"fimea_rel_id": "REL59673",
"authorised_at": "2022-08-23"
}See everything about teclistamab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.